• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA ALTO; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA ALTO; MAIN BODY Back to Search Results
Model Number TV-AB2980-N
Device Problems Material Invagination (1336); Lack of Effect (4065)
Event Date 05/18/2023
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.H3 other text : devices remain implanted.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the alto abdominal aortic aneurysm stent system.At the conclusion of the initial implant procedure, a small type ia endoleak was observed.The patient will continue to be monitored to discern if the endoleak self-resolves at 30-day follow-up.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the alto abdominal aortic aneurysm stent system.At the conclusion of the initial implant procedure, a small type ia endoleak was observed.The patient will continue to be monitored to discern if the endoleak self-resolves at 30-day follow-up.Additional information: it was reported that the type ia endoleak was found resolved per aortogram at two (2) months post initial implant procedure.No additional intervention was required.Aneurysm sac regression was also evident.In addition, clinical assessment identified that infolding of the primary sealing rings was also present at time of event.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported alto, type ia endoleak (resolved) is confirmed.This is consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest an additional endovascular procedure (diagnostic angiogram) and infolding (of the primary sealing rings) occurred that were not included in the event as reported.These findings were discovered during an examination of the three diagnostic angiogram videos and ct (computed tomography) scan dated (b)(6) 2023, respectively.The most likely causation for the reported event is anatomy-related due to the thrombus in the proximal neck, which was taken into account in using the 29mm main body; this cautionary product use condition likely contributed to the infolding.In addition, the infolding of the primary sealing rings likely caused the type ia endoleak.The procedure-related harms identified were a non-endologix device failure (palmaz deployed in distal right common iliac artery).The final patient status was reported as discharged home in stable condition.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: b5 describe event or problem g3 awareness date h6 medical device problem codes; remove 4065 h6 investigation finding codes; remove 3233 h6 investigation conclusion codes; remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTO
Type of Device
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key17125732
MDR Text Key317177561
Report Number3008011247-2023-00077
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00850007370909
UDI-Public(01)00850007370909(17)260208(10)FS020623-30
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 05/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTV-AB2980-N
Device Catalogue NumberTV-AB2980-N
Device Lot NumberFS020623-30
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/18/2023
Initial Date FDA Received06/14/2023
Supplement Dates Manufacturer Received06/29/2023
Supplement Dates FDA Received08/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
OVATION IX ILIAC LIMB, LN FS011623-35; OVATION IX ILIAC LIMB, LN FS072122-53; OVATION IX ILIAC LIMB, LN FS102422-17; OVATION PRIME FILL POLYMER, LN FF020921-01
Patient Outcome(s) Other;
Patient Age78 YR
Patient SexMale
-
-